94 results
8-K
EX-99.2
PSTX
Poseida Therapeutics Inc
17 Apr 24
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
9:17am
and unpredictable Affected areas: Face, oropharynx, extremities, GI, genitourinary tract ‒ Risk of death by asphyxiation ‒ Prolonged attacks, intensifying over … ;S0091-6749(21)00821-6.
The road forward for unmet needs Current state of patient management: – Prevention of death and excessive pain – Reduced
S-8
EX-99.4
3ax qeg05spxcnyv9bxt
8 Feb 24
Registration of securities for employees
4:10pm
8-K
cwf48 xv3vx2hl
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
2gp0t hud
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.3
ti31sq 9fwj6pc5
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.2
78aqy255he71q5wdn8m
11 Dec 23
Regulation FD Disclosure
6:06am
8-K
zzz1ggs1k32d uxl
13 Apr 23
Departure of Directors or Certain Officers
8:06am
8-K
EX-1.1
j27 m92ej
4 Aug 22
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
4:57pm